Fibryga Kit
Product Images NDC 68982-347

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Fibryga (NDC 68982-347). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Octapharma Usa Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image File (Img0001)

Text panel showing a dosing formula for Fibryga (Fibrinogen [Human]) based on body weight. The formula calculates the dose by subtracting the measured fibrinogen level from the target fibrinogen level, divided by 1.8 mg/dL per mg/kg body weight.*

FDA Label Image

Image File (Img0002)

A text panel displaying a formula for dosing calculation based on target and measured fibrinogen levels adjusted for body weight, expressed in mg/kg and mg/dL units.*

FDA Label Image

Image File (Img0003)

An instructional diagram labeled Fig. 1 showing two hands holding a medical component, demonstrating how to press down on the top part and the base simultaneously, indicated by two downward-pointing arrows. The image appears to depict a step in assembling or preparing a medical kit, likely related to the Fibryga fibrinogen kit.*

FDA Label Image

Image File (Img0004)

An instructional diagram showing a hand holding a vial and another hand inserting a stopper or dispenser into the vial. An arrow points downward, indicating the stopper should be pressed down into the vial.*

FDA Label Image

Image File (Img0005)

Instructional illustrations showing how to use the Fibryga (Fibrinogen (Human)) intravenous kit by Octapharma USA Inc. Figure 3 depicts the removal of a cap or stopper from one vial, and Figure 4 shows the insertion of a second vial or component into the first, indicating steps in the kit assembly process.*

FDA Label Image

Image File (Img0006)

An instructional illustration showing how to connect two components of a medical kit. One hand holds a vial upright while the other hand pushes a device or cap downward to attach it securely, indicated by an arrow pointing downwards. A circular inset with an arrow suggests a twisting or aligning motion. This image likely demonstrates part of the preparation or assembly process for an intravenous kit.*

FDA Label Image

Image File (Img0007)

An instructional illustration depicting three steps for preparing a Fibryga kit. Figure 6 shows a hand twisting to remove a cap from a vial. Figure 7 illustrates inserting a syringe or stopper into the opened vial. Figure 8 demonstrates drawing liquid into a syringe from the vial by pulling the plunger downwards.*

FDA Label Image

Image File (Img0008)

A data table presenting virus reduction factors (log10) by production step for enveloped and non-enveloped viruses during the manufacturing process of a plasma derivative product. It includes values for S/D treatment, nanofiltration, and cumulative virus reduction factors for viruses such as HIV-1, PRV, BVDV, HAV, and PPV.*

FDA Label Image

Image File (Img0009)

A table presenting pharmacokinetic parameters including half-life, Cmax, AUC, incremental IVR, clearance, mean residence time, and volume of distribution for Fibryga (Fibrinogen Human) across three subject groups: adult and adolescent, pediatric 6 to <12 years, and pediatric <6 years. Values are expressed as mean ± standard deviation with ranges.*

FDA Label Image

Image File (Img0010)

An instructional diagram labeled 'Fig. 1' showing two hands: one holding a vial and the other pressing down on a cap with arrows indicating downward pressure, likely demonstrating how to secure or activate the cap on the vial.*

FDA Label Image

Image File (Img0011)

An instructional diagram showing a hand removing or placing a cap on a vial using an upward or downward motion. The illustration appears to guide the user on handling the vial cap, likely related to the preparation of Fibryga, a fibrinogen (human) kit for intravenous use.*

FDA Label Image

Image File (Img0012)

Instructional illustrations showing the preparation steps for the Fibryga kit, a fibrinogen (human) intravenous plasma derivative. Fig. 3 depicts a person removing a vial stopper or cap, and Fig. 4 shows a reagent being inserted or added into the vial, indicating aseptic handling during kit assembly.*

FDA Label Image

Image File (Img0013)

An instructional diagram showing a person holding two containers. The top container is inverted and aligned to fit onto the bottom container. An arrow indicates joining the two containers, highlighting the connection step in preparation or assembly of the kit.*

FDA Label Image

Img0014

An instructional diagram consisting of three figures showing procedural steps: Fig. 6 illustrates removing a cap from a vial by pushing down and twisting; Fig. 7 depicts placing an adapter onto the vial; Fig. 8 shows drawing fluid into a syringe from the vial by pulling down on the plunger.*

FDA Label Image

Img0015

Label for Fibryga 1g Range, a fibrinogen (human) intravenous plasma derivative kit. The label includes storage instructions, a note on reconstitution with water for injection, and manufacturer Octapharma USA Inc.'s contact information. It specifies the product is solvent/detergent treated and nanofiltered, for intravenous administration only, and is prescription-only.*

FDA Label Image

Img0016

Fibryga 1g Range lyophilized powder kit for reconstitution with water for injection, intended for intravenous administration. The packaging lists contents including human fibrinogen, sodium chloride, sodium citrate dihydrate, glycine, and L-arginine hydrochloride. Manufactured and distributed by Octapharma USA Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.